[Prognostic significance of inflammatory indicators for advanced-stage diffuse large B-cell lymphoma].

Han, Y; Qin, Y; He, X H; Yang, J L; Liu, P; Zhang, C G; Zhou, L Q; Zhou, S Y; Gui, L; Sun, Y; Shi, Y K

Han, Y; Qin, Y; He, X H; Yang, J L; Liu, P; Zhang, C G; Zhou, L Q; Zhou, S Y; Gui, L; Sun, Y; Shi, Y K.

Afiliação

Han Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.

Zhonghua Yi Xue Za Zhi ; 98(16): 1250-1255, 2018 Apr 24.

Article em Zh | MEDLINE | ID: mdl-29747314

Assuntos

Linfoma Difuso de Grandes Células B; Humanos; Linfócitos; Neutrófilos; Prognóstico; Estudos Retrospectivos

Palavras-chave

Advanced-stage; Diffuse large B-cell lymphoma; Inflammatory indicators; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google